CHARLES PARK: Open Payments
NPI 1629179411 · WEST ORANGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$918 in 60 payments from 12 companies in 2025. Trend: 2023 $618 · 2024 $799 · 2025 $918
Food & beverage: $918
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $394 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $94 |
| Otsuka America Pharmaceutical, Inc. | 5 | $88 |
| Axsome Therapeutics, Inc. | 4 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| Lundbeck LLC | 4 | $65 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Neos Therapeutics, LP | 2 | $36 |
| Almatica Pharma LLC | 1 | $18 |
| Bausch Health US, LLC | 1 | $16 |
Products named: VRAYLAR, REXULTI, CAPLYTA, Auvelity, TRINTELLIX, COBENFY, Adzenys XR-ODT, LOREEV XR.
Industry payments across NJ — which companies pay providers there.
